Vitreous Hemorrhage in Pediatric Patients With X-Linked Retinoschisis: Characteristics and Outcomes

Insights

Vitreous hemorrhage in X-linked retinoschisis (XLRS) often recurs in pediatric patients, despite favorable anatomical outcomes. Fluorescein angiography aids in assessing vascular changes in XLRS.

Area of Science:

  • Ophthalmology
  • Genetics
  • Retinal Diseases

Background:

  • X-linked retinoschisis (XLRS) is a genetic disorder affecting the retina.
  • Vitreous hemorrhage is a potential complication in pediatric patients with XLRS.

Purpose of the Study:

  • To describe the management and outcomes of vitreous hemorrhage in children with XLRS.
  • To evaluate the utility of fluorescein angiography in XLRS patients with vitreous hemorrhage.

Main Methods:

  • Retrospective case series of pediatric patients diagnosed with XLRS and vitreous hemorrhage.
  • Data collected from January 2000 to January 2022 at Bascom Palmer Eye Institute.
  • Included analysis of clinical presentation, interventions, and follow-up outcomes.

Main Results:

  • Nine pediatric patients (12 eyes) with XLRS and vitreous hemorrhage were analyzed.
  • Peripheral capillary dropout was observed in 58.3% of eyes undergoing fluorescein angiography.
  • Fifty percent of eyes were managed conservatively, while 50% received interventions (intravitreal bevacizumab or surgery).
  • Recurrence of vitreous hemorrhage occurred in 58.3% of eyes during the 6-year mean follow-up.
  • All eyes achieved attached retinas and clear media at final follow-up.

Conclusions:

  • Fluorescein angiography is valuable for evaluating the vascular phenotype in XLRS.
  • Pediatric patients with XLRS-related vitreous hemorrhage show good anatomical recovery.
  • Recurrent vitreous hemorrhage is a significant concern in this patient population.
Abstract